Could a common gout pill save legs and lives?
NCT ID NCT07536373
First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times
Summary
This study tests whether a low-dose anti-inflammatory drug called colchicine can help people with severe leg artery disease (chronic limb-threatening ischemia) avoid amputation or death. About 200 adults who recently had a procedure to restore leg blood flow will take either colchicine or a placebo daily for 12 months. The goal is to see if colchicine improves survival without major leg amputation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LIMB-THREATENING ISCHEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chi Mei Medical Center
NOT_YET_RECRUITINGTainan, 710, Taiwan
-
Linkou Chang Gung Memorial Hospital
NOT_YET_RECRUITINGTaoyuan, 333, Taiwan
-
National Taiwan University Hospital
RECRUITINGTaipei, 100, Taiwan
-
Shin Kong Wu Ho-Su Memorial Hospital
RECRUITINGTaipei, Taipei, 111, Taiwan
-
Taipei Veterans General Hospital
NOT_YET_RECRUITINGTaipei, 112, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a sound wave camera inside arteries save more legs?
- Can frailty predict stent failure? new study investigates
- New balloon coated with drug could save limbs in severe artery disease
- New ultrasound technique aims to save limbs in artery disease patients
- Blood thinner duration trial aims to save limbs in severe artery disease
- New device aims to prevent amputation in patients with no other options